Vascular-derived myocardial contractile factor: positive myocardial inotropic substance released from medial layer of the canine aorta.
Interactions between the various cell types that make up the cardiovascular system are known to play an important role in maintaining homeostasis. One area about smooth muscle cells that has received little attention, despite the production of a wide variety of mediators by smooth muscle cells, is their effect on myocardial function. In this study, the myocardial contractile effects of four different types of dog aortic strips on rabbit papillary muscles were evaluated. Of these, medial vascular smooth muscle strips most consistently (65% of the time) produced a "vascular-derived contractile factor" (VDCF), which caused a 15% increase in isometric twitch tension and a 24% increase in isotonic twitch shortening with no change in twitch configuration. Endovascular strips with or without intact endothelium and complete aortic rings had less consistent effects. Vascular-derived contractile factor was stable after freezing at -80 degrees C, its activity was not modified by a broad spectrum peptidase, but it was heat-labile. The angiotensin II blocker, losartan, did not modify its effects. However, incubation with indomethacin did reduce, but did not eliminate, the contractile effects of vascular strips. The addition of alpha 1- and beta-blockers did not further modify the effects of VDCF. Endocardial endothelial removal increased the effects of VDCF. No correlation existed between endothelin levels and the contractile effects of vascular strips. It is concluded that VDCF is produced by the medial layer of large vessels but its exact cellular origin is uncertain. These findings expand the ever-increasing understanding of the inter-relationship between the structures that make up the cardiovascular system, and open the door to new studies evaluating the inter-relationship of vessels and myocardium.
Li
K
K
Department of Medicine, Montreal Heart Institute, University of Montreal, Canada.
Qi
X
X
Andries
L
L
Stewart
D
D
Sirois
P
P
Brutsaert
D
D
Rouleau
J L
JL
D000818:Animals; D001011:Aorta / Q000378:metabolism*; D002316:Cardiotonic Agents / Q000302:isolation & purification / Q000494:pharmacology*; D004285:Dogs; D066298:In Vitro Techniques; D009131:Muscle, Smooth, Vascular / Q000378:metabolism*; D009200:Myocardial Contraction / Q000187:drug effects*; D011817:Rabbits; D013268:Stimulation, Chemical; D017540:Tunica Media / Q000378:metabolism
D002316:Cardiotonic Agents